Instent neointimal hyperplasia after percutaneous intervention for ST-elevation myocardial infarction and treatment with granulocyte-colony stimulating factor. Results from the stem cells in myocardial infarction (STEMMI) trial

International Journal of Cardiology

Volumn 139, Issue 3, 2010, Pages 269-275

  Jørgensen, Erik ^a   Baldazzi, Federica ^a   Ripa, Rasmus S ^a   Friis, Tina ^a   Wang, Yongzong ^a   Helqvist, Steffen ^a   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

Author keywords

G CSF; PCI; Restenosis; SDF 1; STEMI

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; PACLITAXEL; PLACEBO; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CYTOLOGY; ECHOGRAPHY; HEART INFARCTION; HYPERPLASIA; MESENCHYMAL STEM CELL; METHODOLOGY; MIDDLE AGED; NEOINTIMA; PATHOLOGY; PROSPECTIVE STUDY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; HYPERPLASIA; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOINTIMA; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 77957224292     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.029     Document Type: Article

References (30)

1. Focused update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction. In: Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, editors. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, vol. 117. Circulation; 2008. p. 296-329.
2. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. Stone GW, Grines CL, Cox DA, Controlled Abiciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346: 957-66.
5. Montalescot G, Barragan P, Wittenberg O. for the ADMIRAL investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344: 1895-903.
6. Ripa RS, Nilsson JC, Wang Y, Søndergaard L, Jørgensen E, Kastrup J. Short- and long-term changes in myocardial function, morphology, edema and infarct mass following ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. Am Heart J 2007;154:929-36.
7. Orlic D, Kajstura J, Chimenti S. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-9.
8. Kawamoto A, Gwon HC, Iwaguro H. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-7.
9. Valgimigli M, Rigolin GM, Cittanti C. Use of granulocyte- colonystimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 2005;26:1838-45.
10. Ince H, Petzsch M, Kleine HD. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005;112: 3097-106.
11. Ince H, Petzsch M, Kleine HD. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005;112:173-80.
12. Englemann MG, Theiss HD, Hennig-Theiss C. Autologous bone marrow stem cell mobilization induced by granulocyte colonystimulating factor after ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSFSTEMI (Granulocyte Colony Stimulating Factor ST-Segment Elevation Myocardial infarction) trial. J Am Coll Cardiol 2006;48:1712-21.
13. Zohlnhofer D, Ott I, Mehilli J. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295:1003-10.
14. Ellis SG, Penn MS, Bolwell B. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J 2006;152(1051):e9-e14.
15. Kastrup J, Ripa RS, Wang Y, Jørgensen E. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a noninvasive alternative for clinical stem cell therapy? Eur Heart J 2006;27: 2748-54.
16. Ripa SR, Kastrup J. G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction-a relevant treatment? Exp Hematol 2008;36:681-6.
17. Beohar N, Flaherty JD, Davidson CJ. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemiareperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc Interv 2007;69:257-66.
18. Kang HJ, Kim HS, Zhang SY. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
19. Zernecke A, Schober A, Bot I. SDF-1/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96:784-91.
20. Ripa RS, Jorgensen E, Wang Y. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:1983-92.
21. Ripa RS, Haack-Sørensen M, Wang Y. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the stem cells in myocardial infarction (STEMMI) trial. Circulation Sep 11 2007;116(11 Suppl): I24-30.
22. Ince H, Valgimigli M, Petzsch M. Cardiovascular events and restenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis. Heart 2008;94:610-6.
23. SchoberA,Knarren S, LietsM, Lin EA,Weber C. Crucial role of stromal cell-derived factor-1 in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003;108:2491-7.
24. Kong D, Melo LG, Gnecchi M. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair if injured arteries. Circulation 2004;110:2039-46.
25. Askari AT, Unzek S, Popovic ZB. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
26. Fukada D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointimal after coronary stent implantation. J Am Coll Cardiol 2004;43:18-23.
27. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003;107:1757-63.
28. Schober A, Hoffmann R, Oprèe N. Peripheral CD34+ cells and risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol 2005;96:1116-22.
29. Overgaard M, et al. Int J Cardiol. In press.
30. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.